Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone for Prevention of Corticosteroid-Induced Glucose Intolerance
NCT00240604Phase 3Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Apr 2005
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rosiglitazone in glucose intolerance, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
rosiglitazone
03
Conditions
glucose intolerance
Beyond the preview
Go deeper on NCT00240604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240604.